Curtis A. Hanson, M.D., has been selected to serve on the Center for Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests. The panel was established by the Protecting Access to Medicare Act (PAMA) of 2014 and will play a crucial role in providing input on the establishment of payment rates for new clinical laboratory tests.
“Dr. Hanson brings more than 27 years of clinical laboratory-testing experience, pathology expertise, and insight into laboratory operational concerns that can serve this Panel well,” wrote Mayo Clinic President and CEO John Noseworthy, M.D., in his nomination letter. “He has been a practicing physician and researcher at Mayo Clinic since 1993, and from 2002 to 2006, Dr. Hanson was chair of Mayo’s Department of Laboratory Medicine and Pathology and Mayo Medical Laboratories. These dual leadership roles strongly positioned him to understand industry and national laboratory-management issues.”
Alan Mertz, President of the American Clinical Laboratory Association, wrote in his nomination letter, “Dr. Hanson would bring a unique and valuable perspective to the panel, as his experience spans the clinical, research, academic, and business practices of laboratory medicine. . . . I believe that coming from an organization like Mayo Clinic, which is recognized consistently for excellence in health care and the value it brings to payors, Dr. Hanson has a great deal to offer the advisory panel as it discusses coverage and payment for new clinical diagnostic laboratory tests.”
We are proud that Dr. Hanson has been selected to serve on this panel. He will bring leadership, experience, integrity, and skill to this role.